CINCINNATI — Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced its wholly owned subsidiary, Meridian Life Science, Inc. (MLS) has opened a new office in Beijing, China. The office is located on Chang-An Avenue (close to Tiananmen Square and government offices) on the 15th floor in the New China Life Insurance (NCI) Tower Center, in […]

HILDEN, Germany, and GERMANTOWN, Maryland -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it had exceeded its goal for 250 new placements of the QIAsymphony modular automation solution in 2014, bringing the total number of cumulative placements to more than 1,250 at year-end. QIAGEN also announced its fifth U.S. regulatory decision […]

SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided an update on operational and preliminary financial results for the year ended December 31, 2014. Financial Highlights include: Total revenue for 2014 is expected to be in the range of $47.0 to $48.0 million, […]

Cambridge, UK — Sphere Medical Holding plc (AIM: SPHR.L) (“Sphere Medical” or the “Company”), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, today announces the appointment of Dr David Martyr and Meinhard Schmidt to the Company’s Board as Non-Executive Directors with immediate effect. Dr Martyr has held several senior […]

Germantown, Maryland, and Hilden -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the CE product launch of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth generation of the most accurate test for detecting tuberculosis (TB) infections. QFT-Plus builds on the legacy of QuantiFERON-TB Gold, which was the third-generation version of this important technology that […]

Matsudo, Japan and Paris, France — Precision System Science, Co., Ltd. (PSS) and The ELITech Group (ELITech) jointly announce that the companies have extended their relationship into a Development and Supply Agreement. Under an exclusive OEM arrangement, PSS will develop and supply “geneLEADXII” instrument, a fully automated Real-Time PCR analyzer, on which ELITech’s ELITe MGB […]

AMSBIO has announced several products suitable for the development of an ELISA detection assay for the Ebola virus. The new products comprise 3 different monoclonal antibodies to the Ebola virus and 2 recombinant proteins (from the Sudan and Zaire strains) suitable for use in producing an optimised ELISA test kit for Ebola. An antigen-capture enzyme-linked […]

SAN DIEGO — BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics, has signed a 15-year lease for a new 360,000 square foot, state-of-the-art, build-to-suit campus in Foster City, CA. This agreement represents one of the largest life science lease transactions in the country over the […]

SUNNYVALE, Calif. — Cepheid (Nasdaq: CPHD) today announced that Andrew Miller, executive vice president and chief financial officer, will be leaving Cepheid to pursue an opportunity with PTC Inc., a Massachusetts-based technology solutions provider. Mr. Miller will continue to serve as Cepheid’s CFO through February 3, 2015, directing Cepheid’s financial operations and assisting with the […]

PROVO, Utah — Tute Genomics, already a standard bearer in the clinical genomics industry, has added even more valuable experience and proven leadership to its team with the naming of Andrew Olson as vice president of sales. “Tute Genomics is uniquely positioned to lead the revolution in genome­-guided precision medicine,” said Olson. “With the most […]